TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
19 hedge funds and large institutions have $374K invested in Titan Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
1
Closed
3
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$7K
Top Buyers
1 |
Renaissance Technologies
New York
|
+$115K |
2 |
VF
Virtu Financial
New York
|
+$35K |
3 |
Millennium Management
New York
|
+$29.3K |
4 |
HF
HRT Financial
New York
|
+$29K |
5 |
UBS Group
Zurich,
Switzerland
|
+$11K |
Top Sellers
1 |
AC
Armistice Capital
New York
|
-$826K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$73.8K |
3 |
Barclays
London,
United Kingdom
|
-$48K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10K |